Advances in Lentiviral Technology and Manufacturing Processes
Time: 12:15 pm
day: Day 2 - Track C - Morning
Details:
- Novel lentiviral genomes and associated technology to improve productivity, quality, and enhanced safety
- Generation of stable, inducible, lentiviral vector producer cell lines (PCL’s) for CAR therapy
- Development of an improved production process to increase yield, reduce residual contaminants and improve quality
